KRW 8520.0
(4.41%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -140.25 KRW | -125.93% |
2022 | 540.97 KRW | 59547.25% |
2021 | -0.91 KRW | -100.15% |
2020 | 593.97 KRW | -37.95% |
2019 | 957.31 KRW | 142.57% |
2018 | 394.65 KRW | 354.98% |
2017 | 86.74 KRW | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -337.79 KRW | -23.89% |
2024 Q2 | -1078.35 KRW | -219.24% |
2023 Q3 | 230.52 KRW | 165.7% |
2023 Q4 | -272.65 KRW | -218.28% |
2023 FY | - KRW | -125.93% |
2023 Q2 | 86.76 KRW | 145.6% |
2023 Q1 | -190.25 KRW | -148.5% |
2022 Q2 | 16.19 KRW | 185.12% |
2022 FY | - KRW | 59547.25% |
2022 Q4 | 392.29 KRW | 130.08% |
2022 Q3 | 170.50 KRW | 953.12% |
2022 Q1 | -19.02 KRW | 96.87% |
2021 FY | - KRW | -100.15% |
2021 Q4 | -607.79 KRW | -259.39% |
2021 Q3 | 381.32 KRW | 0.0% |
2020 FY | - KRW | -37.95% |
2019 FY | - KRW | 142.57% |
2018 FY | - KRW | 354.98% |
2017 FY | - KRW | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 9148.00 KRW | 101.533% |
InBody Co.,Ltd | 2819.01 KRW | 104.975% |
Curexo Inc. | -120.00 KRW | -16.875% |
Seegene, Inc. | 14.19 KRW | 1088.372% |
i-SENS, Inc. | 134.89 KRW | 203.974% |
Gencurix Inc. | -1629.25 KRW | 91.392% |
Sugentech Inc. | -1090.00 KRW | 87.133% |
L&C Bio Co., Ltd | 2096.33 KRW | 106.69% |